Federal antitrust enforcement is entering a period of uncertainty in the second Trump administration. It is an open question what priorities Andrew Ferguson, the newly-appointed Federal Trade Commission (FTC) Chair, and Gail...more
On April 23, 2024, the Federal Trade Commission (FTC) voted to publish a final rule that, effective 120 days after publication, will ban the use of non-compete clauses nationwide, classifying such clauses as an unfair method...more
On 5 January 2023, the Federal Trade Commission (FTC) released a Notice of Proposed Rulemaking (NPRM) for the Non-Compete Clause Rule. The proposed rule, if adopted, would effectively ban the use of non-competes with...more
The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time. In this week's Report: FDA issues...more
The Covid-19 pandemic has caused upheaval across labor markets and resulted in what some have termed the “Great Resignation.” In the midst of these challenging labor market conditions, employers should be aware that the U.S....more
The COVID-19 pandemic has affected U.S. health care in an unprecedented way, requiring hospitals, providers, and suppliers to collaborate to respond to the urgency of the crisis. The situation has also put pressure on...more
Read the latest news on antitrust, competition and economic regulation (ACER) in this Spring's edition of our quarterly ACER newsletter.
...more
7/17/2019
/ ACPERA ,
Antitrust Provisions ,
AT&T ,
Competition ,
Department of Justice (DOJ) ,
Federal Trade Commission (FTC) ,
FinTech ,
FRAND ,
Health Care Providers ,
Hospitals ,
Leniency Programs ,
Pharmaceutical Industry ,
Public Procurement Policies ,
Regulatory Standards ,
Sherman Act ,
Total Cost of Care Model (TCOC) ,
Whistleblowers
Read the latest news on antitrust, competition and economic regulation (ACER) in this Winter's edition of our quarterly ACER newsletter.
...more
4/3/2019
/ Antitrust Provisions ,
Bid Rigging ,
CFIUS ,
Economic Development ,
EU ,
Federal Trade Commission (FTC) ,
Foreign Direct Investment ,
Government Shutdown ,
Hold-Separate Remedies ,
Merger Controls ,
No-Poaching ,
Pharmaceutical Patents ,
Public Procurement Policies ,
Regulatory Standards ,
South Africa ,
UK Competition and Markets Authority (CMA)
Over the last several weeks, the U.S. Department of Justice (DOJ) submitted notices of intent to file statements of interest in five "no-poach" class actions.
...more
FTC takes another look at merger remedies -
On 3 February 2017, the U.S. Federal Trade Commission (“FTC”) released its Merger Remedies Study, which analyzed the success of merger remedies imposed by the FTC from 2006 to...more
2/23/2017
/ Africa ,
Anti-Monopoly ,
Antitrust Provisions ,
Best Practices ,
Cartels ,
China ,
COMESA ,
Competition ,
Department of Justice (DOJ) ,
EU ,
European Commission ,
Extradition ,
Federal Trade Commission (FTC) ,
Gun-Jumping ,
Hart-Scott-Rodino Act ,
Hong Kong ,
Human Resources Professionals ,
Hungary ,
INTERPOL ,
Merger Controls ,
Mexico ,
MOFCOM ,
NRDC ,
PEMEX ,
Pharmaceutical Industry ,
Pre-Merger Filing Requirements ,
Railways ,
Red Notices ,
Regulatory Oversight ,
Remedies ,
Resale Pricing ,
Retail Market ,
Settlement ,
Transportation Industry ,
Trump Administration ,
UK